Of course we'll need more cash at some stage, theres plenty going on in other areas beside this trial, but imo the next raise (provided positive ongoing results) would be a placement potentially to a pharma. I think it better to have some stock, rather than try and wait to potentially get discounted CR shares that may/never come. Good results here we raise at a premium not a discount. Everyone has there own risk reward ideas but if/when this proves to work could overnight jump to multiples of this price
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-28
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.0¢ |
Change
-0.015(1.78%) |
Mkt cap ! $102.6M | |||
| Open | High | Low | Value | Volume |
| 84.5¢ | 85.5¢ | 82.0¢ | $69.84K | 82.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2733 | 82.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.5¢ | 3700 | 1 |
View Market Depth
| Last trade - 15.58pm 05/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |